Search Results 601-610 of 12970 for risksas

  1. Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion - Mayo Clinic

    Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion · Share ...

  2. A Study of the Zenith® p-Branch® Endovascular Graft for Treatment of Abdominal Aortic Aneurysms - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  4. Breast cancer - Doctors and departments - Mayo Clinic

    HER2-positive breast cancer: What is it? Infographic: Breast Cancer Risk · Lumpectomy · Modified radical mastectomy · Nipple changes · Paulas story A team ...

  5. Neurology - Clinical trials - Mayo Clinic

    The purpose of this research is to develop stem cells from cells within patients' skin in order to better understand peripheral neuropathy and help develop ...

  6. Study of Repetitive Transcranial Magnetic Stimulation (rTMS) in Depressed Teens - Mayo Clinic

    This research study aims to test the safety and effectiveness of repetitive transcranial magnetic stimulation (rTMS) on teens with depression. The study also ...

  7. Extension Study Of ACT-EARLY - Mayo Clinic

    About this study. To evaluate the long-term safety and tolerability of acoramidis in participants with newly diagnosed ATTR-CM ...

  8. Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. Breast cancer - Doctors and departments - Mayo Clinic

    Analyzing the genetic makeup of breast cancer cells to understand how DNA changes affect response to cancer treatments and personalize treatment options.

  10. A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ - Mayo Clinic

    H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer.